18,000
Participants
Start Date
April 1, 2025
Primary Completion Date
July 31, 2028
Study Completion Date
July 31, 2028
Norepinephrine
Intravenous Norepinephrine for both infusion and bolus dosing
Phenylephrine
Intravenous Phenylephrine for both infusion and bolus dosing
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
University of California, San Francisco, San Francisco
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Michigan
OTHER
Henry Ford Health System
OTHER
University of Washington
OTHER
University of Texas Southwestern Medical Center
OTHER
Wake Forest University Health Sciences
OTHER
University of Virginia
OTHER
University of Maryland
OTHER
Duke University
OTHER
University of California, San Francisco
OTHER